Mononuclear cytotoxicity and proliferation towards glucose stimulated rodent pancreatic islet cells

Autoimmunity

Volumn 25, Issue 2, 1997, Pages 97-108

  Ekblond, A ^a   Schou, M ^a   Buschard, K ^a  

^a Department of Rheumatology and the Osteoporosis Research Centre   (Denmark)

Author keywords

Autoimmunity; Cytotoxicity; IDDM; Islet cells

Indexed keywords

GLUCOSE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CYTOTOXICITY; EFFECTOR CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONONUCLEAR CELL; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; SPLEEN CELL; TARGET CELL;

EID: 0030911825     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939708996276     Document Type: Article

References (54)

1. Buschard, K. The functional state of the beta cells in the pathogenesis of insulin dependent diabetes mellitus. Autoimmunity 1991; 10: 65-70.
2. Kolb, H., Ben-nun, A., Cohen, I. R., Barberena, I., Kiesel, U. Autoimmune T-lymphocytes with specificity for pancreatic islet antigens. Immunology Letters 1985; 9: 29-32.
3. Roep, B. O., Arden, S., de Vries, R. R. P., Hutton, J. C. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 1990; 345: 632-634.
4. Botazzo, G. F., Death of beta cell: Homicide or suicide?. Diab. Med. 1986; 3: 119-30.
5. Di Mario, U., Dotta, F. Modulation of Antigen Expression in Relation to Intervention Strategies in Type 1 Diabetes. Diab. Metab. Rev. 1993; 9: 245-249.
6. Pipeleers, D., Kiekens, R., Ling, Z., Wilikens, A., Schuit, F. Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 1994; 37 (supplement 2): S57-S64.
7. Gotfredsen, C. F., Buschard, K., Frandsen, E. K. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985; 28: 933-935.
8. Atkinson, M. A., Maclaren, N. K., Luchetta, R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39: 933-937.
9. Gottlieb, P. A., Handler, E. S., Appel, M. C., Greiner, D. L., Mordes, J. P., Rossini, A. A. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats. Diabetologia 1991; 34: 296-300.
10. Bertrand, S., De Paepe, M., Vigeant, C., Yale, J.-F. Prevention of adoptive transfer in BB rats by prophylactic insulin treatment. Diabetes 1992; 41: 1273-1277.
11. Like, A. A. Insulin injections prevent diabetes in Bio Breeding/Worcester (BB/Wor) rats. Diabetes 1986; 35 (supplement 1): 74A.
12. Portha, B., Picon, L. Insulin treatment improves the spontanous remission of neonatal streptozotocin diabetes in the rat. Diabetes 1982; 31: 165-169.
13. Thivolet, C. H., Goillot, E., Bedossa, P., Durand, A., Bonnard, M., Orgiazzi, J. Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia 1991; 34: 314-319.
14. Shah, S. C., Malaone, J. I., Simpson, N. E. A randomised trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. New Eng. J. Med. 1989; 320: 550-554.
15. Colman, P, G., Nayak, R. C., Campbell, I. L., Eisenbarth, G. S. Binding of cytoplasmatic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 1988; 37: 645-652.
16. West, D. B., Seino, Y., Woods, S. C., Porte, D. Ventromedial hypothalamic lesions increase pancreatic sensitivity to streptozotocin in rats. Diabetes 1980; 29: 948-951.
17. Buschard, K., Buch, I., Molsted-Pedersen, L., Hougaard, P., Kuhl, C. Increased incidence of true type 1 diabetes during pregnancy. Brit. Med. J. 1987; 294: 275-279.
18. Buschard, K., Brogren, C. H., Røpke, C., Rygaard, J. Antigen expression of the pancreatic beta-cells is dependent on their functional state, as shown by a specific. BB rat monoclonal autoantibody IC2. APMIS 1988; 96: 342-346.
19. Aaen, K., Rygaard, J., Josefsen, K., et al. Dependence of antigen expression onfunctional state of beta-cells. Diabetes 1990; 39: 697-701.
20. Appel, M. C., Dotta, F., O'Neil, J. J., Eisenbarth, G. S. B-cell activity regulates the expression of islet antigenetic determinants. Diabetologia 1989; 32: 461A.
21. Mordes, J. P., Desemone, J., Rossini, A. A. The BB rat. Diab. Metab. Rev. 1987; 3: 725-750.
22. Nerup, J., Andersen, O. O., 8endixen, G., Egeberg, J., Poulsen, J. E. Antipancreaticcellular hypersensitivity in diabetes mellitus. Diabetes 1971; 20: 424-427.
23. Diaz, J.-L., Ways, J., Hammonds, P. T-lymphocyte lines specific for Glutamic Acid Decarboxylase (GAO) the 64K beta-cell antigen of IDDM. Diabetes 1992; 41 118-121.
24. Backkeskov, S., Aanstoot, H. J., Christgau, S., et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-sythesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
25. Michelsen, B. K., Petersen, J. S., Boel, E., Møldrup, A., Dyrberg, T., Madsen, O. D. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 1991; 88: 8754-8758.
26. Kaufman, D. L., Erlander, M. G., Clare-Salzier, M., Atkinson, M. A., Maclaren, N. K., Tobin, A. J. Autoimmunity to two forms of Glutamat Decarboxylase in insulin-dependent Diabetes Mellitus. J. Clin. Inv. 1992; 89: 283-292.
27. Bjoerk, E., Kaempe, O., Andersson, A., Karlsson, F. A. Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia 1992; 32: 490-493.
28. Nakamura, N., Woda, B. A., Tafuri, A., et al. Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro. Diabetes 1990; 39: 836-843.
29. Ashcroft, S. J. H., Hammonds, P., Harrison, D. E. Insulin secretory responses of a clonal cell line of simian virus 40 transformed B cells. Diabetologia 1986; 29: 727-733.
30. Roep, B. O., Kallan, A. A., Hazenbos, W. L., et al. T-cell reactivity to 38 kD insulin-secretory-granulc protein in patients with recent-onset type 1 diabetes. Lancet 1991; 337: 1439-1441.
31. Feige, U., Cohen, I. R. The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice. Springer Semin. Immunopathol. 1991; 13: 99-113.
32. Nomoto, K., Yoshikai, Y. Heat-shock proteins and immunopathology: regulatory role of heat-shock protein-specific T cells. Springer Semin. Immunopathol. 1991; 13: 63-80.
33. Elias, D., Reshef, T., Birk, O. S., Van der Zee, R., Walker, M. D., Cohen, I. R. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA. 1991; 88: 3088-3091.
34. Pedersen, C. R., Josefsen, K., Bock, T., Hansen, S. V., Buschard. K. Beta-cell expression of 65-kDa heat-shock protein mRNA is function- and age-dependent. APMIS 1992; 100: 765-771.
35. Sandler, S., Bendtzen, K., Eizirik, D. L., Strandell, E., Welsh, M., Welsh, N. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration. Immunology Letters 1990; 26: 245-252.
36. Eizirik, D. L., Strandell, E., Sandler, S. Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin. Diabetologia 1988; 31: 168-174.
37. Palmer, J. P., Helqvist, S., Spinas, G. A., et al. Interaction of Beta-Cell Activity and IL-1 Concentration and exposure Time in Isolated Rat Islets of Langerhans. Diabetes 1989; 38: 1211-1216.
38. Burkart, V., Brenner, H.-H., Hartmann B, Kolb, H. Metabolic activation improves the resistance of islet cells to toxic attack. European Association for the Study of Diabetes 30th annual meeting, Dusseldorf 1994; A97: 377. [Abstract]
39. Koevary, B. S., Williams, D. E., Williams, R. M., Chick, W. L. Passive transfer of diabetes from BB/W to Wistar-Furth rats. J. Clin. Invest. 1985; 75: 1904-1907.
40. Buschard, K. The thymus-dependent immune system in the pathogenesis of type I (insulin-dependent) diabetes mellitus. Danish Med. Bul. 1985; 32: 139-151.
41. Weringer, E. J., Like, A. A. Diabetes mellitus in the BB/W rat. Insulitis in pancreatic islet grafts after transplantation in diabetic recipients. AJP 1986; 125: 107-112.
42. Debray-Sachs, M., Boitard, C., Timsit, J., Bach, J. F. Specific anti-islet immuniy in NOD mice: In vitro studies. In: Jaworski, M. A., Molnar, G. O., Rajotte, R. V., Singh, B., eds. The immunology of diabetes mellitus. Excepta Medica 1986. Int. congress series 717, 1986: 147.
43. Pipeleers, D., Ling, Z. Pancreatic Beta Cells in Insulin-Dependent Diabetes. Diab. Metab. Rev. 1992; 8: 209-227.
44. Hansen, A. K., Dagnaes-Hansen F. An introduction to the use of rodent models in diabetes research. LI. Skensved, Ry.: Moellegaard Ltd, Bomholdtgaard Ltd., 1990.
45. Miyazaki, J.-I., Araki, K., Yamato, E., et al. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinol. 1990; 127: 126-132.
46. Sutton, R., Peters, M., McShane, P., Gray, D. W. R., Morris, P. J. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplant 1986; 42: 689-691.
47. Josefsen, K., Hansen, W. A., Kjaer, T. W., et al. Optimizing fluoroscens activated cell sorting (FACS) of pancreatic endocrine cells. Diabetes 1990; 39 suppl 1: 149A.
48. Josefsen, K., Stenvang, J.-P., Kindmark, H., et al. Flourescence-activated cell sorted rat islet cells and studies of the insulin secretory process. J. Endocrinol. 1996; 149: 145-154.
49. Charles, A. M., Suzuki, M., Waldeck, N., et al. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. J. Immunol. 1983; 130: 1189-94.
50. Davalli, A. M., Ricordi, C., Socci, C., et al. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J. Clin. Endocrin. Metab. 1991; 72: 202-208.
51. Davalli, A. M.. Pontirollo, A. E., Socci, C., et al. Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: Evidence supporting specific desensitization rather than beta-cell exhaustion. J. Clin. Endocrin. Metab. 1992; 74: 790-794.
52. Boitard, C. Review. The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects. Diabetologia 1992; 35: 1101-1112.
53. Boitard, C., Larger, E., Timsit, J., Sempe, P., Bach, J. F. IDDM: an islet or an immune disease? Diabetologia 1994; 37 (suppl 2): S90-S98.
54. Kæmpe, O., Andersson, A., Bjørk, E., Hallberg, A., Karlsson, F. A. High-Glucose Stimulation of 64,00-Mr Islet Cell Autoantigen Expression. Diabetes 1989; 38: 1326-1328.